U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254884) titled 'Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring' on Oct. 01.
Brief Summary: The primary objective of this clinical trial is to evaluate the safety and effectiveness of the 2,910 nm mid-infrared erbium-doped fluoride fiber glass laser (UltraClear, Acclaro Medical) for non-invasive dermatological aesthetic treatment of three facial regions: eyebrow lift (Region 1), submental tissue lift (Region 2), and improvement of rhytids and skin laxity in the cheeks, midface, and jawline (Region 3).
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Rhytids
Skin Laxity
Intervention:
DEVICE: 2,910 nm m...